Search

Benjamin Purow Phones & Addresses

  • 1527 Rugby Rd, Charlottesville, VA 22903 (434) 409-7977
  • Charlottesvle, VA
  • Silver Spring, MD
  • Staten Island, NY
  • Baltimore, MD

Work

Company: Emily Couric Clinical Cancer Center Address: 1240 Lee St, Charlottesville, VA 22903

Education

School / High School: Johns Hopkins University School Of Medicine 1996

Ranks

Certificate: American Board of Pediatrics Certification in Pediatrics

Images

Professional Records

License Records

Benjamin W. Purow

Address:
911 Elm Ave, Takoma Park, MD 20010
License #:
MD30364 - Expired
Category:
MEDICINE
Issued Date:
Jul 16, 1997
Expiration Date:
Dec 31, 2000
Type:
MEDICINE AND SURGERY

Medicine Doctors

Benjamin Purow Photo 1

Dr. Benjamin W Purow - MD (Doctor of Medicine)

View page
Procedures:
Prolactinoma
Neurofibroma
Chemotherapy
Glioblastoma
Oligodendroglioma
Meningioma
Hospitals:
Emily Couric Clinical Cancer Center
1240 Lee St, Charlottesville, VA 22903

West Complex
1300 Jefferson Park Ave, Charlottesville, VA 22903

Fontaine Medical Office Building 1
415 Ray C Hunt Dr, Charlottesville, VA 22903

University of Virginia Hospital
1215 Lee Street, Charlottesville, VA 22908
Education:
Medical Schools
Johns Hopkins University School Of Medicine
Graduated: 1996
Benjamin Purow Photo 2

Benjamin W. Purow

View page
Specialties:
Neurology, Medical Oncology
Work:
University Virginia Cancer Center Neuro Oncology
1240 Lee St, Charlottesville, VA 22908
(434) 982-4415 (phone), (434) 982-4467 (fax)
Education:
Medical School
Johns Hopkins University School of Medicine
Graduated: 1996
Procedures:
Chemotherapy
Conditions:
Anemia
Anxiety Dissociative and Somatoform Disorders
Leukemia
Malignant Neoplasm of Female Breast
Non-Hodgkin's Lymphoma
Languages:
English
Description:
Dr. Purow graduated from the Johns Hopkins University School of Medicine in 1996. He works in Charlottesville, VA and specializes in Neurology and Medical Oncology. Dr. Purow is affiliated with University Of Virginia Medical Center.
Benjamin Purow Photo 3

Benjamin W Purow, Charlottesville VA

View page
Specialties:
Neurological Surgery
Pediatrics
Pediatric Hematology-Oncology
Neurology
Work:
Neuro-Oncology
1215 Lee St, Charlottesville, VA 22908
UVA Health Services Foundation
Hospital Dr W, Charlottesville, VA 22908
UVA Health Services Foundation
Lee St, Charlottesville, VA 22908
University of Virginia Physicians Group
1300 Jpa Ave, Charlottesville, VA 22903
Education:
Johns Hopkins University (1996)
Benjamin Purow Photo 4

Benjamin Warren Purow, Charlottesville VA

View page
Specialties:
Neurosurgeon
Address:
500 Ray C Hunt Dr, Charlottesville, VA 22903
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics

Business Records

Name / Title
Company / Classification
Phones & Addresses
Benjamin Warren Purow
Benjamin Purow MD
Pediatric Oncologist · Neurologist · Neurosurgeon · Pediatrician
1215 Lee St, Charlottesville, VA 22908
(434) 982-4415

Publications

Us Patents

Sheath Device With Dressing For Prevention Of Pneumothorax.

View page
US Patent:
7244245, Jul 17, 2007
Filed:
Mar 17, 2003
Appl. No.:
10/390457
Inventors:
Benjamin Warren Purow - Takoma Park MD, US
Michael P. Chu - Chicago IL, US
International Classification:
A61M 5/32
US Classification:
604180, 128898
Abstract:
A sheath device comprises a substantially rigid elongated body adapted to receive a chest tube. The body includes a first end and a second end, flexible seal at the first end, and an air-impermeable flexible joint at the second end. A base having a first side and a second side is provided at the joint, wherein the first side is connected with the flexible joint and the second side includes an adhesive for securing the base to a patient's chest. A method of preventing pneumothorax in a patient having a chest tube removed comprises attaching the sheath device to the patient's chest at the time of the chest tube placement, later withdrawing the chest tube into the airtight chamber of the sheath, and sealing the sheath device. Removing the base and flexible joint of the sheath device from the body of the sheath device leaves an air-impermeable dressing on the patient's chest.

Sheath Device With Dressing For Prevention Of Pneumothorax

View page
US Patent:
6569121, May 27, 2003
Filed:
Oct 12, 2000
Appl. No.:
09/689545
Inventors:
Benjamin Warren Purow - Takoma Park MD, 20912
Michael P. Chu - Chicago IL, 60657
International Classification:
A61M 532
US Classification:
604174, 604180, 128898
Abstract:
A sheath device comprises a substantially rigid elongated body adapted to receive a chest tube. The body includes a first end and a second end, flexible seal at the first end, and an air-impermeable flexible joint at the second end. A base having a first side and a second side is provided at the joint, wherein the first side is connected with the flexible joint and the second side includes an adhesive for securing the base to a patients chest. A method of preventing pneumothorax in a patient having a chest tube removed comprises attaching the sheath device to the patients chest at the time of the chest tube placement, later withdrawing the chest tube into the airtight chamber of the sheath, and sealing the sheath device. Removing the base and flexible joint of the sheath device from the body of the sheath device leaves an air-impermeable dressing on the patients chest.

Compositions And Methods For Diagnosing And Treating Nucleotide Repeat Disorders

View page
US Patent:
20160340732, Nov 24, 2016
Filed:
May 17, 2016
Appl. No.:
15/156626
Inventors:
- Charlottesville VA, US
Benjamin W. PUROW - Charlottesville VA, US
International Classification:
C12Q 1/68
A61K 31/7088
A61K 31/167
A61K 31/16
A61K 31/19
Abstract:
The present application discloses compositions and methods useful for diagnosing and treating nucleotide repeat disorders. An in silico analysis indicates a striking and specific miR-NRD homology. Validated miR target prediction software was used to assess each NRD nucleotide repeat expansion for potential miR homology. The striking degree of matched homology and the one-to-one expansion-to-miR ratio strongly support their relevance to the corresponding NRD and serve as a basis for therapeutic treatments. It is also disclosed herein that NETO is involved in mediating C9-repeat glutamate excitotoxicity, thus representing a novel therapeutic target.
Benjamin W Purow from Charlottesville, VA, age ~55 Get Report